PD-L1, often upregulated on tumor cells or immune cells within the TME, binds to PD-1 on activated T cells, suppressing their proliferation, cytokine production, and cytotoxic activity (Pauken and Wherry, 2015; Wherry et al., 2007). This evidence concerns the gene PDCD1 and neoplasm.